Jefferies Upgrades Bristol-Myers Squibb Co. (BMY) to Buy, 'Why we're upgrading'
Tweet Send to a Friend
Jefferies analyst Akash Tewari upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy with a price target of $70.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
